Ionis Pharmaceuticals (IONS) PT Lowered to $94 at TD Cowen
TD Cowen analyst Yaron Werber lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $94.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
